Craft

Femasys

Stock Price

$1.4

2024-10-29

Market Capitalization

$30.7 M

2024-10-29

Revenue

$2.3 M

FY, 2025

Femasys Summary

Company Summary

Overview
Femasys is a biomedical company that provides women’s healthcare solutions including minimally invasive and non-surgical product technologies. It offers two product candidates: FemBloc for permanent birth control and FemaSeed as an artificial insemination infertility treatment.
Type
Public
Status
Active
Founded
2004
HQ
Suwanee, GA, US | view all locations
Website
http://www.femasys.com/
Cybersecurity rating
Sectors

Key People

  • Kathy Lee-Sepsick

    Kathy Lee-Sepsick, President & CEO

  • Lexy Kelley

    Lexy Kelley, Vice President, Clinical & Medical Affairs

LocationsView all

1 location detected

  • Suwanee, GA HQ

    United States

    3950 Johns Creek Ct #100

Femasys Financials

Summary Financials

Revenue (Q1, 2026)
$424.9K
Gross profit (Q1, 2026)
$266.3K
Net income (Q1, 2026)
$846.1K
Cash (Q1, 2026)
$5.4M
EBIT (Q1, 2026)
($4.2M)
Enterprise value
$26.7M

Footer menu